<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Lithium</strong></td></tr><tr><th>Accession Number</th><td><strong>DB01356</strong></td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>Lithium was used during the 19th century to treat gout. Lithium salts such as lithium carbonate (Li2CO3), lithium citrate, and lithium orotate are mood stabilizers. They are used in the treatment of bipolar disorder, since unlike most other mood altering drugs, they counteract both mania and depression. Lithium can also be used to augment other antidepressant drugs. It is also sometimes prescribed as a preventive treatment for migraine disease and cluster headaches. The active principle in these salts is the lithium ion Li+, which having a smaller diameter, can easily displace K+ and Na+ and even Ca+2, in spite of its greater charge, occupying their sites in several critical neuronal enzymes and neurotransmitter receptors.</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB01356/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB01356/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01356.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01356.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01356.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01356.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01356.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB01356">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Salts</th><td class="table-container"><table class="inner">
  <thead>
    <tr>
      <th>Name/CAS</th>
      <th>Structure</th>
      <th>Properties</th>
      <th></th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>
          <strong>Lithium carbonate</strong>
          <div class="cas"></div>
        </td>
        <td><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DBSALT001075/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DBSALT001075/thumb.png"></a></td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
        <td><a class="btn btn-default btn-xs" href="/salts/DBSALT001075">DBSALT001075</a></td>
      </tr>
  </tbody>
</table></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Eskalith</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>LITHOBID</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>LithoTab</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>CAS number</th><td>7439-93-2</td></tr><tr><th>Weight</th><td>Average: 6.941<br>Monoisotopic: 7.016004049</td></tr><tr><th>Chemical Formula</th><td>Li</td></tr><tr><th>InChI Key</th><td>HBBGRARXTFLTSG-UHFFFAOYSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/Li/q+1</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">lithium(1+) ion</div></td></tr><tr><th>SMILES</th><td><div class="wrap">[Li+]</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Inorganic Compounds</td></tr><tr><th>Superclass</th><td>Homogeneous Metal Compounds</td></tr><tr><th>Class</th><td>Homogeneous Alkali Metal Compounds</td></tr><tr><th>Subclass</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Direct parent</th><td>Homogeneous Alkali Metal Compounds</td></tr><tr><th>Alternative parents</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Substituents</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Classification description</th><td>This compound belongs to the homogeneous alkali metal compounds. These are inorganic compounds containing only metal atoms,with the largest atom being a alkali metal atom.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>Lithium is used as a mood stabilizer, and is used for treatment of depression and mania. It is often used in bipolar disorder treatment.</td></tr><tr><th>Pharmacodynamics</th><td>Although lithium has been used for over 50 years in treatment of bipolar disorder, the mechanism of action is still unknown. Lithium's therapeutic action may be due to a number of effects, ranging from inhibition of enzymes such as glycogen synthase kinase 3, inositol phosphatases, or modulation of glutamate receptors. </td></tr><tr><th>Mechanism of action</th><td>The precise mechanism of action of Li+ as a mood-stabilizing agent is currently unknown. It is possible that Li+ produces its effects by interacting with the transport of monovalent or divalent cations in neurons. An increasing number of scientists have come to the conclusion that the excitatory neurotransmitter glutamate is the key factor in understanding how lithium works. Lithium has been shown to change the inward and outward currents of glutamate receptors (especially GluR3), without a shift in reversal potential. Lithium has been found to exert a dual effect on glutamate receptors, acting to keep the amount of glutamate active between cells at a stable, healthy level, neither too much nor too little.  It is postulated that too much glutamate in the space between neurons causes mania, and too little, depression. Another mechanism by which lithium might help to regulate mood include the non-competitive inhibition of an enzyme called inositol monophosphatase.  Alternately lithium's action may be enhanced through the deactivation of the GSK-3B enzyme.  The regulation of GSK-3B by lithium may affect the circadian clock.  GSK-3 is known for phosphorylating and thus inactivating glycogen synthase. GSK-3B has also been implicated in the control of cellular response to damaged DNA. GSK-3 normally phosphorylates beta catenin, which leads to beta catenin degratation. When GSK-3 is inhibited, beta catenin increases and transgenic mice with overexpression of beta catenin express similar behaviour to mice treated with lithium. These results suggest that increase of beta catenin may be a possible pathway for the therapeutic action of lithium. </td></tr><tr><th>Absorption</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Metabolism</th><td class="data-table-container"></td></tr><tr><th>Route of elimination</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Half life</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Affected organisms</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.8382</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.9708</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              +
        </td>
        <td>0.7056</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Non-substrate
        </td>
        <td>0.8831</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9869</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9855</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9199</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.8465</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.823</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.8094</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8854</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9224</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9559</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9487</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9853</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.9015</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.9663
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Carcinogens  
        </td>
        <td>
            0.623
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Ready biodegradable 
        </td>
        <td>
            0.9031
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.0881 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.9462
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.9716
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Noven therapeutics llc</li>
<li>Jds pharmaceuticals llc</li></ul></td></tr><tr><th>Packagers</th><td><ul><li>Advanced Pharmaceutical Services Inc.</li>
<li><a href="http://www.amerisourcebergen.com">Amerisource Health Services Corp.</a></li>
<li>Anip Acquisition Co.</li>
<li><a href="http://www.apotex.com">Apotex Inc.</a></li>
<li><a href="http://www.biotechpharma.com.au">Biotech Pharmaceuticals</a></li>
<li><a href="http://www.cardinal.com">Cardinal Health</a></li>
<li><a href="http://www.caremark.com">Caremark LLC</a></li>
<li>Comprehensive Consultant Services Inc.</li>
<li>Coupler Enterprises Inc.</li>
<li>Dept Health Central Pharmacy</li>
<li>Direct Dispensing Inc.</li>
<li><a href="http://www.drxdispensing.com">Dispensing Solutions</a></li>
<li><a href="http://www.dhscorp.com">Diversified Healthcare Services Inc.</a></li>
<li><a href="http://www.glenmark-generics.com">Glenmark Generics Ltd.</a></li>
<li>Goldline Laboratories Inc.</li>
<li>Heartland Repack Services LLC</li>
<li><a href="http://www.heterodrugs.com">Hetero Drugs Ltd.</a></li>
<li><a href="http://www.hikma.com">Hikma Pharmaceuticals</a></li>
<li><a href="http://www.jtbaker.com">J T Baker</a></li>
<li>Kaiser Foundation Hospital</li>
<li>Lake Erie Medical and Surgical Supply</li>
<li>Liberty Pharmaceuticals</li>
<li><a href="http://www.majorpharmaceuticals.com">Major Pharmaceuticals</a></li>
<li><a href="http://www.mckesson.com">Mckesson Corp.</a></li>
<li><a href="http://www.unitdosesupply.com">Murfreesboro Pharmaceutical Nursing Supply</a></li>
<li>Neuman Distributors Inc.</li>
<li><a href="http://www.noven.com">Noven Pharmaceuticals Inc.</a></li>
<li><a href="http://www.nucarerx.com">Nucare Pharmaceuticals Inc.</a></li>
<li><a href="http://www.palmettopharm.com">Palmetto Pharmaceuticals Inc.</a></li>
<li>Pharmacy Service Center</li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li>Prepackage Specialists</li>
<li><a href="http://www.prepaksys.com">Prepak Systems Inc.</a></li>
<li><a href="http://www.rebelrx.com">Rebel Distributors Corp.</a></li>
<li><a href="http://www.remedyrepack.com">Remedy Repack</a></li>
<li>Resource Optimization and Innovation LLC</li>
<li><a href="http://www.roxane.com">Roxane Labs</a></li>
<li><a href="http://www.sandhillspackaging.com">Sandhills Packaging Inc.</a></li>
<li><a href="http://global.abbottgrowth.com">Solvay Pharmaceuticals</a></li>
<li><a href="http://www.southwoodhealthcare.com">Southwood Pharmaceuticals</a></li>
<li><a href="http://statrxusa.exporterus.com">Stat Rx Usa</a></li>
<li><a href="http://www.sunpharma.com">Sun Pharmaceutical Industries Ltd.</a></li>
<li>Tya Pharmaceuticals</li>
<li><a href="http://www.udllabs.com">UDL Laboratories</a></li>
<li>Vangard Labs Inc.</li>
<li><a href="http://www.west-ward.com">West-Ward Pharmaceuticals</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Capsule</td><td>Oral</td><td></td></tr><tr><td>Liquid</td><td>Oral</td><td></td></tr><tr><td>Syrup</td><td>Oral</td><td></td></tr><tr><td>Tablet, extended release</td><td>Oral</td><td></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB01223">Aminophylline</a></td><td>Theophylline decreases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB08822">Azilsartan medoxomil</a></td><td>Azilsartan medoxomil may increase lithium serum concentrations.</td></tr><tr><td><a href="/drugs/DB00542">Benazepril</a></td><td>The ACE inhibitor increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00436">Bendroflumethiazide</a></td><td>The thiazide diuretic, bendroflumethiazide, may increase serum levels of lithium.</td></tr><tr><td><a href="/drugs/DB00562">Benzthiazide</a></td><td>The thiazide diuretic, benzthiazide, may increase serum levels of lithium.</td></tr><tr><td><a href="/drugs/DB00201">Caffeine</a></td><td>Caffeine decreases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00796">Candesartan</a></td><td>The ARB increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB01197">Captopril</a></td><td>The ACE inhibitor increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00482">Celecoxib</a></td><td>The COX-2 inhibitor increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00880">Chlorothiazide</a></td><td>The thiazide diuretic, chlorothiazide, may increase serum levels of lithium.</td></tr><tr><td><a href="/drugs/DB00310">Chlorthalidone</a></td><td>The thiazide diuretic, chlorthalidone, may increase serum levels of lithium.</td></tr><tr><td><a href="/drugs/DB01340">Cilazapril</a></td><td>The ACE inhibitor increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB04272">Citric Acid</a></td><td>The urine alkalizer decreases the effect of lithium</td></tr><tr><td><a href="/drugs/DB00606">Cyclothiazide</a></td><td>The thiazide diuretic, cyclothiazide, may increase serum levels of lithium.</td></tr><tr><td><a href="/drugs/DB06700">Desvenlafaxine</a></td><td>Increased risk of serotonin syndrome. Monitor for symptoms of serotonin syndrome.</td></tr><tr><td><a href="/drugs/DB00586">Diclofenac</a></td><td>The NSAID, diclofenac, may decrease the renal excretion of lithium. Increased risk of lithium toxicity.</td></tr><tr><td><a href="/drugs/DB00861">Diflunisal</a></td><td>The NSAID, diflunisal, may decrease the renal excretion of lithium. Increased risk of lithium toxicity. </td></tr><tr><td><a href="/drugs/DB00651">Dyphylline</a></td><td>Theophylline decreases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00584">Enalapril</a></td><td>The ACE inhibitor increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00700">Eplerenone</a></td><td>Eplerenone increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00876">Eprosartan</a></td><td>The ARB increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB01628">Etoricoxib</a></td><td>Etoricoxib increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00472">Fluoxetine</a></td><td>The SSRI, fluoxetine, increases serum levels of lithium.</td></tr><tr><td><a href="/drugs/DB00176">Fluvoxamine</a></td><td>The SSRI, fluvoxamine, increases serum levels of lithium.</td></tr><tr><td><a href="/drugs/DB01342">Forasartan</a></td><td>The ARB increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00492">Fosinopril</a></td><td>The ACE inhibitor increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00502">Haloperidol</a></td><td>Possible extrapyramidal effects and neurotoxicity with this combination</td></tr><tr><td><a href="/drugs/DB00999">Hydrochlorothiazide</a></td><td>The thiazide diuretic, hydrochlorothiazide, may increase serum levels of lithium.</td></tr><tr><td><a href="/drugs/DB00774">Hydroflumethiazide</a></td><td>The thiazide diuretic, hydroflumethiazide, may increase serum levels of lithium.</td></tr><tr><td><a href="/drugs/DB01050">Ibuprofen</a></td><td>The NSAID, ibuprofen, may decrease the renal excretion of lithium. Increased risk of lithium toxicity.</td></tr><tr><td><a href="/drugs/DB00808">Indapamide</a></td><td>The thiazide diuretic, indapamide, may increase serum levels of lithium.</td></tr><tr><td><a href="/drugs/DB00328">Indomethacin</a></td><td>The NSAID, indomethacin, may decrease the renal excretion of lithium. Increased risk of lithium toxicity.</td></tr><tr><td><a href="/drugs/DB05247">Iodine</a></td><td>Possible hypothyroidism with this combination</td></tr><tr><td><a href="/drugs/DB01029">Irbesartan</a></td><td>The ARB increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB01009">Ketoprofen</a></td><td>The NSAID, ketoprofen, may increase the serum concentration of lithium by decreasing its renal clearance. Consider a dose reduction in lithium upon initiation of ketoprofen therapy. Monitor for changes in the therapeutic and adverse effects of lithium if ketoprofen is initiated, discontinued or does changed. </td></tr><tr><td><a href="/drugs/DB00465">Ketorolac</a></td><td>The NSAID, ketorolac, may decrease the renal excretion of lithium. Increased risk of lithium toxicity.</td></tr><tr><td><a href="/drugs/DB00722">Lisinopril</a></td><td>The ACE inhibitor increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00678">Losartan</a></td><td>Losartan increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB01283">Lumiracoxib</a></td><td>The COX-2 inhibitor increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00784">Mefenamic acid</a></td><td>The NSAID, mefenamic acid, may decrease the renal excretion of lithium. Increased risk of lithium toxicity.</td></tr><tr><td><a href="/drugs/DB00814">Meloxicam</a></td><td>Meloxicam increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00232">Methyclothiazide</a></td><td>The thiazide diuretic, methyclothiazide, may increase serum levels of lithium.</td></tr><tr><td><a href="/drugs/DB00968">Methyldopa</a></td><td>Methyldopa may increase the adverse effects of lithium without affecting lithium serum levels. Monitor for signs and symptoms of lithium toxicity during concomitant therapy.</td></tr><tr><td><a href="/drugs/DB00524">Metolazone</a></td><td>The thiazide diuretic, metolazone, may increase serum levels of lithium.</td></tr><tr><td><a href="/drugs/DB00916">Metronidazole</a></td><td>Metronidazole increases the effect and toxicity of lithium</td></tr><tr><td><a href="/drugs/DB00691">Moexipril</a></td><td>The ACE inhibitor increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00788">Naproxen</a></td><td>The NSAID, naproxen, may decrease the renal excretion of lithium. Increased risk of lithium toxicity.</td></tr><tr><td><a href="/drugs/DB01303">Oxtriphylline</a></td><td>Theophylline decreases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00790">Perindopril</a></td><td>The ACE inhibitor increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00812">Phenylbutazone</a></td><td>The NSAID, phenylbutazone, may decrease the renal excretion of lithium. Increased risk of lithium toxicity.</td></tr><tr><td><a href="/drugs/DB00554">Piroxicam</a></td><td>The NSAID, piroxicam, may decrease the renal excretion of lithium. Increased risk of lithium toxicity.</td></tr><tr><td><a href="/drugs/DB01324">Polythiazide</a></td><td>The thiazide diuretic, polythiazide, may increase serum levels of lithium.</td></tr><tr><td><a href="/drugs/DB01345">Potassium</a></td><td>The urine alkalizer decreases the effect of lithium</td></tr><tr><td><a href="/drugs/DB00881">Quinapril</a></td><td>The ACE inhibitor increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB01325">Quinethazone</a></td><td>The thiazide diuretic, quinethazone, may increase serum levels of lithium.</td></tr><tr><td><a href="/drugs/DB00178">Ramipril</a></td><td>The ACE inhibitor increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00533">Rofecoxib</a></td><td>The COX-2 inhibitor increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB01347">Saprisartan</a></td><td>The ARB increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB01105">Sibutramine</a></td><td>Possible serotoninergic syndrome with this combination</td></tr><tr><td><a href="/drugs/DB01390">Sodium bicarbonate</a></td><td>The urine alkalizer decreases the effect of lithium</td></tr><tr><td><a href="/drugs/DB01348">Spirapril</a></td><td>The ACE inhibitor increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00669">Sumatriptan</a></td><td>Possible serotoninergic syndrome with this combination</td></tr><tr><td><a href="/drugs/DB01349">Tasosartan</a></td><td>The ARB increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00966">Telmisartan</a></td><td>Telmisartan may increase serum Lithium concentrations. Monitor serum Lithium levels during concomitant therapy to avoid Lithium toxicity.</td></tr><tr><td><a href="/drugs/DB00469">Tenoxicam</a></td><td>Tenoxicam may increase the serum concentration of Lithium. A dose adjustment of Lithium may be required. Monitor for changes in Lithium therapeutic and adverse effects if Tenoxicam is initiated, discontinued or dose changed.</td></tr><tr><td><a href="/drugs/DB04844">Tetrabenazine</a></td><td>Inhibit biochemical and behavioural effects of tetrabenazine. Heed caution when using agents in combination. </td></tr><tr><td><a href="/drugs/DB00277">Theophylline</a></td><td>Theophylline decreases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB01600">Tiaprofenic acid</a></td><td>Tiaprofenic acid may increase the therapeutic/adverse effects of Lithium by increasing Lithium serum concentrations. Monitor for changes in the therapeutic/adverse effects of Lithium if Tiaprofenic acid is initiated, discontinued or dose changed. </td></tr><tr><td><a href="/drugs/DB00684">Tobramycin</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00500">Tolmetin</a></td><td>Tolmetin may increase the risk of Lithium toxicity by decreasing the renal elminiation of Lithium. A dose adjustment of Lithium may be required. Monitor for changes in Lithium therapeutic and adverse effects if Tolmetin is initiated, discontinued or dose changed. </td></tr><tr><td><a href="/drugs/DB00273">Topiramate</a></td><td>Topiramate could modify lithium levels</td></tr><tr><td><a href="/drugs/DB00519">Trandolapril</a></td><td>Trandolapril may increase the serum concentration of Lithium increasing the risk of Lithium toxicity. Monitor for changes in Lithium serum concentrations, toxicity and efficacy if Trandolapril is initiated, discontinued or dose changed.</td></tr><tr><td><a href="/drugs/DB00752">Tranylcypromine</a></td><td>Increased risk of serotonin syndrome. Use caution during concomitant therapy and monitor for symptoms of serotonin syndrome. </td></tr><tr><td><a href="/drugs/DB00656">Trazodone</a></td><td>Increased risk of serotonin syndrome. Monitor for symptoms of serotonin syndrome.</td></tr><tr><td><a href="/drugs/DB01021">Trichlormethiazide</a></td><td>Trichlormethiazide may increase the serum concentration of Lithium by decreasing Lithium excretion. Monitor for changes in the therapeutic/adverse effects of Lithium if Trichlorthiazide is initiated, discontinued or dose changed.</td></tr><tr><td><a href="/drugs/DB00726">Trimipramine</a></td><td>Increased risk of serotonin syndrome. Monitor for symptoms of serotonin syndrome. </td></tr><tr><td><a href="/drugs/DB00580">Valdecoxib</a></td><td>The COX-2 inhibitor increases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00177">Valsartan</a></td><td>Valsartan may increase serum lithium concentrations. Monitor serum lithium levels during concomitant therapy to avoid lithium toxicity.</td></tr><tr><td><a href="/drugs/DB00285">Venlafaxine</a></td><td>Increased risk of serotonin syndrome. Monitor for symptoms of serotonin syndrome.</td></tr><tr><td><a href="/drugs/DB00661">Verapamil</a></td><td>Signs of lithium toxicity</td></tr><tr><td><a href="/drugs/DB00315">Zolmitriptan</a></td><td>Use of two serotonin modulators, such as zolmitriptan and lithium, increases the risk of serotonin syndrome. Consider alternate therapy or monitor for serotonin syndrome during concomitant therapy. </td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><ul><li>Avoid alcohol.</li>
<li>Avoid excessive quantities of coffee or tea (Caffeine).</li>
<li>Avoid iodine supplements.</li>
<li>Do not change your salt intake from day to day without telling your doctor.</li>
<li>Take with food to reduce irritation. Drink plenty of liquids.</li></ul></td></tr></tbody></table>